Expert Interview
Discussing the positive results from the Phase 2 Study of NTLA-2002, an investigational in vivo CRISPR gene editing treatment for HAE
Ticker(s): NTLAInstitution: The Doctors Clinic
- Board certified is Allergy-Immunology and Internal Medicine
- sees adult and pediatric patients for a wide range of allergic and immmunologic conditions.
- treats 8-10 patients annually for HAE and has prescribed Haegarda, Orladeyo, and Takhzyro
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
